Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate

Loma Linda University (LLU)

Status

Withdrawn

Conditions

Colonic Polyps

Treatments

Device: AmplifEYE

Study type

Interventional

Funder types

Other

Identifiers

NCT02885987

5160326

Details and patient eligibility

About

The purpose of this investigator-initiated study is to determine whether the use of an accessory device called AmplifEYE can improve colonoscopy quality in patients who are undergoing average risk colorectal cancer screening. Primary end point is adenoma detection rates.

Sex

All

Ages

50 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

All adult patients greater than or at 50 years of age who are referred for average risk screening colonoscopy.

Exclusion criteria

Any pregnant patient
Patient's that are unable to provide consent for themselves
Any patient undergoing diagnostic colonoscopy (IBD, rectal bleeding, recent change in bowel habits, etc.)
Any patient undergoing surveillance (prior history of polyps or colorectal cancer)
Any patient undergoing high risk screening colonoscopy (family history of colon cancer in first degree family member <65 years of age, or co-existing conditions that pre-dispose to colon cancer such as polyposis syndromes, PSC or IBD)
Prior history of any cancer
Current or past immunosuppression (due to either infection or medications)
Coagulation disorder OR use of anti-coagulation or anti-platelet therapy other than aspirin within 5-7 days of procedure
Colonic strictures
suspected intestinal obstruction or colonic pseudo-obstruction
history of colon resection
active infection
active inflammation (including diverticulitis)